NCT03043833 is a NA clinical trial of The Wellbeing Course in Major Depression, sponsored by Universite de Moncton.

Who is sponsoring NCT03043833?

NCT03043833 is sponsored by Universite de Moncton.

What drugs are being tested in NCT03043833?

Interventions in NCT03043833: The Wellbeing Course.

What condition does NCT03043833 study?

NCT03043833 studies Major Depression, Anxiety Disorders.

Is NCT03043833 still recruiting?

NCT03043833 is currently completed. Last updated 1 May 2018.

Last reviewed 2018-05-01 · How we verify

NCT03043833

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Internet-Delivered Cognitive Behavior Therapy for Anxiety and Depression Amongst French Canadians

Completed NA Last updated 1 May 2018

What this trial tests

NA trial testing The Wellbeing Course in Major Depression in 64 participants. Completed in 30 March 2018.

Timeline

18 January 2017

Primary endpoint
30 January 2018

30 March 2018

Quick facts

Lead sponsor	Universite de Moncton
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	64
Start date	18 January 2017
Primary completion	30 January 2018
Estimated completion	30 March 2018
Sites	1 location across Canada

Drugs / interventions tested

The Wellbeing Course

Conditions studied

Major Depression — all drugs for Major Depression →
Anxiety Disorders — all drugs for Anxiety Disorders →

Sponsor

Universite de Moncton

Who can join

Adults 18 to 80, any sex, with Major Depression or Anxiety Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study represents Phase II of a research program involving an international collaboration with Macquarie University (Sydney, Australia) to implement an Internet-based cognitive behavior therapy for the treatment of anxiety and depression in French-speaking Canadians from the Atlantic Provinces. The primary objective is to establish the clinical efficacy of a French-Canadian self-guided format version of the Wellbeing Course by conducting a randomized-control trial where an experimental group will be compared to a waitlist control group. A secondary objective is to demonstrate the course's acceptability through participants' satisfaction with the course.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Major Depression

Currently open trials in the same condition.

NCT07031817 — Validation of a Composite Medical Device Using a Blood Biomarker-based Algorithm and MDQ for the Diagnosis of Bipolar Di · NA · recruiting
NCT07184697 — Efficacy and Safety of Task-specific, Biomarker-driven, HD-ctACS inTRD. · NA · active not recruiting
NCT07463911 — Treatment Response In ECT Patients · active not recruiting
NCT06763081 — Pharmacogenomics of Selective Serotonin Reuptake Inhibitor (SSRI)-Induced Behavioural Activation · recruiting
NCT06781593 — Combining Light Therapy and CPAP in Depression · NA · recruiting

Other Universite de Moncton trials

Trials by the same sponsor.

NCT06534203 — Physical Task Demands of Caregivers Working in a Long-Term Care Facility · recruiting
NCT05278377 — Effectiveness of the Apprenti en Action School-based Culinary Program on 9-10-year-old Children's Food Literacy · completed
NCT04605224 — Effectiveness of a Culinary Class on Food Literacy and Eating Behaviours of Francophone High School Students · completed
NCT03354351 — Comorbid Mental Disease and Heart Disease in Men · unknown
NCT03156556 — Improving Access to the Treatment of Anxiety and Depression Among Young Adults · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03043833 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universite de Moncton
Last refreshed: 1 May 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03043833.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing